| Anti-diabetic drugs and weight loss in patients with type 2 diabetes E Lazzaroni, MB Nasr, C Loretelli, I Pastore, L Plebani, ME Lunati, ... Pharmacological Research 171, 105782, 2021 | 102 | 2021 |
| The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists G Bendotti, L Montefusco, ME Lunati, V Usuelli, I Pastore, E Lazzaroni, ... Pharmacological Research 182, 106320, 2022 | 94 | 2022 |
| Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) F Bifari, R Manfrini, M Dei Cas, C Berra, M Siano, M Zuin, R Paroni, F Folli Pharmacological research 137, 219-229, 2018 | 68 | 2018 |
| Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on hemodialysis M Mirani, C Berra, S Finazzi, A Calvetta, MG Radaelli, F Favareto, ... Diabetes technology & therapeutics 12 (10), 749-753, 2010 | 65 | 2010 |
| Anti-inflammatory effect of SGLT-2 inhibitors via uric acid and insulin R La Grotta, P de Candia, F Olivieri, G Matacchione, A Giuliani, MR Rippo, ... Cellular and Molecular Life Sciences 79 (5), 273, 2022 | 62 | 2022 |
| Glucagon improves insulin secretion from pig islets in vitro F Bertuzzi, C Berra, C Socci, AM Davalli, G Calori, M Freschi, L Piemonti, ... Journal of endocrinology 147 (1), 87-93, 1995 | 42 | 1995 |
| Blood pressure control in type 2 diabetes mellitus with arterial hypertension. The important ancillary role of SGLT2-inhibitors and GLP1-receptor agonists C Berra, R Manfrini, D Regazzoli, MG Radaelli, O Disoteo, C Sommese, ... Pharmacological Research 160, 105052, 2020 | 36 | 2020 |
| Hypoglycemia and hyperglycemia are risk factors for falls in the hospital population C Berra, F De Fazio, E Azzolini, M Albini, F Zangrandi, M Mirani, ... Acta diabetologica 56, 931-938, 2019 | 34 | 2019 |
| Intercellular Ca2+ waves sustain coordinate insulin secretion in pig islets of Langerhans F Bertuzzi, D Zacchetti, C Berra, C Socci, G Pozza, AE Pontiroli, ... FEBS letters 379 (1), 21-25, 1996 | 30 | 1996 |
| SGLT2-inhibitors are effective and safe in the elderly: The SOLD study ME Lunati, V Cimino, A Gandolfi, M Trevisan, L Montefusco, I Pastore, ... Pharmacological Research 183, 106396, 2022 | 29 | 2022 |
| Telemedicine and urban diabetes during COVID-19 pandemic in Milano, Italy during lock-down: epidemiological and sociodemographic picture L Luzi, M Carruba, R Crialesi, S Da Empoli, R Dagani, E Lovati, ... Acta diabetologica 58, 919-927, 2021 | 29 | 2021 |
| The role of patient preferences in adherence to treatment in chronic disease: a narrative review S Losi, CCF Berra, R Fornengo, D Pitocco, G Biricolti, MO Federici Drug target insights 15, 13, 2021 | 25 | 2021 |
| Clinical efficacy and predictors of response to dulaglutide in type-2 diabetes CC Berra, V Resi, M Mirani, L Folini, A Rossi, SB Solerte, P Fiorina Pharmacological research 159, 104996, 2020 | 25 | 2020 |
| Immunogenicity and safety of SARS-CoV-2 mRNA vaccines in a cohort of patients with type 1 diabetes F D’Addio, G Sabiu, V Usuelli, E Assi, A Abdelsalam, A Maestroni, ... Diabetes 71 (8), 1800-1806, 2022 | 24 | 2022 |
| Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting N Simioni, C Berra, M Boemi, AC Bossi, R Candido, G Di Cianni, ... Acta Diabetologica 55, 557-568, 2018 | 23 | 2018 |
| Long-term effectiveness of liraglutide for treatment of type 2 diabetes in a real-life setting: a 24-month, multicenter, non-interventional, retrospective study A Lapolla, C Berra, M Boemi, AC Bossi, R Candido, G Di Cianni, ... Advances in Therapy 35, 243-253, 2018 | 22 | 2018 |
| Liraglutide and cardiovascular outcomes in a real world type 2 diabetes cohort M Mirani, G Favacchio, E Serone, G Lucisano, MC Rossi, CC Berra Pharmacological Research 137, 270-279, 2018 | 20 | 2018 |
| Long-term in vitro exposure to high glucose increases proinsulin-like-molecules release by isolated human islets F Bertuzzi, K Saccomanno, C Socci, AM Davalli, MV Taglietti, C Berra, ... Journal of endocrinology 158 (2), 205-212, 1998 | 17 | 1998 |
| Once‐weekly semaglutide use in patients with type 2 diabetes: real‐world data from the SURE Italy observational study R Napoli, C Berra, AM Catarig, C Di Loreto, E Donatiello, TL Berentzen, ... Diabetes, Obesity and Metabolism 25 (6), 1658-1667, 2023 | 14 | 2023 |
| Impact of insulin degludec in type 2 diabetes: real-world data on effectiveness and safety P Ponzani, C Berra, A Di Lelio, P Del Sindaco, C Di Loreto, F Reggiani, ... Diabetes Therapy 9, 2209-2218, 2018 | 14 | 2018 |
